Life sciences briefing: Tuesday, Jan. 29, 2008
TODAY’S HEADLINES:
Immune-system specialty pharma Circassia raises £11M (release)
Cancer-biomarker biotech CS-Keys takes in $6.3M (release)
Neuro-robotic device maker Myomo receives $3M (VentureWire)
Micropharma draws C$1.8M for nutraceutical delivery (VentureWire)
Avalon Labs gets $66M for disposable life-support components (release)
Gloucester Pharma names Alan Colowick as CEO (release)
ConforMIS names Philipp Lang as CEO (release)
Pharma-marketing firm TargetRx names Craig Scott as CEO (release)
Immune-system specialty pharma Circassia raises £11M – Circassia, an Oxford, England biotech focused on immune-system disorders, raised £11 million ($21.8 million) in… Continue Reading
Life sciences briefing: Monday, Nov. 5, 2007
Featured companies: AvidBiotics, Codexis, Imalux, Myomo
UPDATED: Expanded items on AvidBiotics and Codexis.
AvidBiotics raises $1M for anti-infective drugs — AvidBiotics, a South San Francisco, Calif., biotech developing a new generation of antibacterial proteins, raised $1 million in a first funding round, VentureWire reports (subscription required). The company didn’t disclose its investors.
AvidBiotics is using a new type of protein engineering to develop molecules that can successfully attack drug-resistant bacterial. That engineering system relies upon a “diversity generator” that produces… Continue Reading